Calcium ion antagonists, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers were prescribed significantly more often in CTD patients with cardiovascular involvement (p < 0.05) (Table 5), which may due to higher hypertension prevalence in this population. This evidence concerns the gene ACE and Hypertension.